# RenovoRx (RNXT) — Earnings

RNXT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rnxt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.06 |
| EPS estimate | −$0.07 |
| EPS surprise | +17.24% |
| Revenue surprise | +29.17% |
| Revenue | $909,000.00 |
| Revenue estimate | $703,750.00 |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1574094/000119312526349190/rnxt-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/7dd81b8d-b1f7-9e1c-8cc5-c980d4ad3a67.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | −$0.07 | −$0.06 | 17.24% | $703,750.00 | $909,000.00 |
| Q1 2026 | May 14, 2026 | −$0.08 | −$0.09 | -12.50% | $469,500.00 | $563,000.00 |
| Q4 2025 | Mar 30, 2026 | −$0.08 | −$0.08 | 0.00% | $419,700.00 | $238,000.00 |
| Q3 2025 | Nov 13, 2025 | −$0.08 | −$0.08 | 0.00% | $405,400.00 | $266,000.00 |
| Q2 2025 | Aug 14, 2025 | −$0.09 | −$0.08 | 5.88% | $329,633.00 | $422,000.00 |
| Q1 2025 | May 15, 2025 | −$0.08 | −$0.08 | 0.00% | $183,333.00 | $197,000.00 |
| Q4 2024 | Apr 1, 2025 | −$0.11 | −$0.11 | 0.00% | — | $43,000.00 |
| Q3 2024 | Nov 13, 2024 | −$0.12 | −$0.10 | 14.31% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.11 | −$0.10 | 4.76% | — | — |
| Q1 2024 | May 10, 2024 | −$0.13 | −$0.07 | 46.15% | — | — |
| Q4 2023 | Apr 1, 2024 | −$0.31 | −$0.30 | 1.64% | — | — |
| Q3 2023 | Nov 13, 2023 | −$0.28 | −$0.13 | 53.57% | — | — |
| Q2 2023 | Aug 16, 2023 | −$0.29 | −$0.22 | 24.14% | — | — |
| Q4 2022 | Mar 2, 2023 | −$0.26 | −$0.24 | 7.69% | — | — |
| Q3 2022 | Nov 14, 2022 | −$0.29 | −$0.24 | 17.24% | — | — |
| Q4 2021 | Mar 30, 2022 | −$0.16 | −$0.27 | -74.19% | — | — |
| Q3 2021 | Nov 15, 2021 | −$0.21 | −$0.23 | -7.14% | — | — |

## Frequently Asked Questions

### When did RenovoRx (RNXT) last report earnings?

RenovoRx last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did RNXT beat earnings estimates?

Yes. RenovoRx reported EPS of −$0.06 for Q2 2026 against a −$0.07 estimate — a 17.24% beat.

### How much revenue did RNXT report last quarter?

RenovoRx reported $909,000.00 in revenue for Q2 2026, against a consensus estimate of $703,750.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).